Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers retrieved 9 April 2024 from https://medicalxpress.com/news/2024-04-personalized-vaccine-clinical-benefit-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Investigational gene therapy shows promise for rare childhood neurodegenerative diseaseAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health.
Source: NewsMedical - 🏆 19. / 71 Read more »

Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
Source: medical_xpress - 🏆 101. / 51 Read more »

Investigational therapeutic shows promise in preclinical pancreatic cancer modelA new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease, suggesting it has the potential to offer novel treatment options for nearly all pancreatic tumors, a comprehensive study has found.
Source: medical_xpress - 🏆 101. / 51 Read more »